

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | NASDAQ | USD | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZNCF | OTC Markets | USD | Delayed | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZN | London | GBP | Real-time | |
AZNN | Mexico | MXN | Delayed | |
AZNN | BIVA | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Xetra | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Frankfurt | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
(Reuters) - AstraZeneca (NASDAQ:AZN) said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in the United States for the treatment of BRCA-mutated...
AstraZeneca (NASDAQ:AZN) and Merck & Co., Inc’s, known as MSD outside the US and Canada, LYNPARZA® (olaparib) in combination with abiraterone and prednisone or prednisolone has been approved in the US...
AstraZeneca (NASDAQ:AZN) and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been approved in the US for the treatment of adult patients with deleterious...
AstraZeneca (NASDAQ:AZN) today announced the discontinuation of the brazikumab inflammatory bowel disease (IBD) development programme, an anti-IL-23 monoclonal antibody, being investigated for the...
By Joe Cash BEIJING (Reuters) -A majority of British companies are taking a "wait and see approach" on new investments in China amid their pessimism hitting record levels, according to the British...
By Joe Cash and Brenda Goh BEIJING (Reuters) - Global drugmaker AstraZeneca (NASDAQ:AZN) will seek to be a patriotic company in China that "loves the Communist Party", its China president said at an...
By Raghav Mahobe and Mariam Sunny (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc (NYSE:PFE)'s experimental respiratory...
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc (NASDAQ:AMGN)'s $27.8 billion acquisition of Horizon...
By Maggie Fick LONDON (Reuters) -AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review